A previous study, focussing on cardiovascular and diabetes medication, showed that older patients on polypharmacy had more positive attitudes towards stopping statins as compared to stopping antihypertensives, and that they appeared to be more reluctant to stop insulin as compared to stopping other diabetes or cardiovascular medication [18]. This evidence concerns the gene INS and diabetes mellitus.